Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, synaptic dysfunction, and pathological accumulation of amyloid‐β (Aβ) and hyperphosphorylated tau [1, 2]. This evidence concerns the gene MAPT and Alzheimer disease.